These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 2657600)

  • 1. An update on candidate malaria vaccines.
    Mitchell GH
    Parasitology; 1989; 98 Suppl():S29-47. PubMed ID: 2657600
    [No Abstract]   [Full Text] [Related]  

  • 2. The development of molecular vaccines against malaria sporozoites.
    Ballou WR; Young JF; Cryz SJ; Sadoff JC
    Adv Exp Med Biol; 1989; 251():295-313. PubMed ID: 2692428
    [No Abstract]   [Full Text] [Related]  

  • 3. Parasitology. Malaria--from infants to genomics to vaccines.
    Long CA; Hoffman SL
    Science; 2002 Jul; 297(5580):345-7. PubMed ID: 12130768
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to the circumsporozoite protein and protective immunity to malaria sporozoites.
    Jones TR; Ballou WR; Hoffman SL
    Prog Clin Parasitol; 1993; 3():103-17. PubMed ID: 7678379
    [No Abstract]   [Full Text] [Related]  

  • 5. Human immune responses against sexual stages of malaria parasites: considerations for malaria vaccines.
    Mendis KN; David PH; Carter R
    Int J Parasitol; 1990 Jul; 20(4):497-502. PubMed ID: 2210943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines. Searching for a parasite's weak spot.
    Taubes G
    Science; 2000 Oct; 290(5491):434-7. PubMed ID: 11183756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell functions in Plasmodium falciparum and other malarias.
    Troye-Blomberg M; Perlmann P
    Prog Allergy; 1988; 41():253-87. PubMed ID: 3043421
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanisms of immunity to malaria and the possibilities of a blood-stage vaccine: a critical appraisal.
    Butcher GA
    Parasitology; 1989 Apr; 98 Pt 2():315-27. PubMed ID: 2668863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host immune response to Plasmodium.
    Kabilan LS
    Indian J Malariol; 1991 Sep; 28(3):189-96. PubMed ID: 1822458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation.
    Good MF; Kumar S; Miller LH
    Immunol Today; 1988 Nov; 9(11):351-5. PubMed ID: 3076406
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaccine development. Which way for malaria?
    Cox FE
    Nature; 1988 Feb; 331(6156):486-7. PubMed ID: 3124000
    [No Abstract]   [Full Text] [Related]  

  • 12. Sporozoite immunity and vaccine development.
    Hockmeyer WT; Ballou WR
    Prog Allergy; 1988; 41():1-14. PubMed ID: 3043419
    [No Abstract]   [Full Text] [Related]  

  • 13. Malaria vaccines: scientific and ethical issues.
    Tosta CE
    Rev Inst Med Trop Sao Paulo; 1992 Apr; 34 Suppl 9():S33-40. PubMed ID: 1340632
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of asexual blood stage malaria vaccines.
    Kidson C
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):391-6. PubMed ID: 3064322
    [No Abstract]   [Full Text] [Related]  

  • 15. Selecting candidate antigens for malaria vaccines.
    Kidson C; Saul A; Schofield L; Upcroft J; Don M; Read D; Myler P; Castelino D; Chiu S; Ingram L
    Asian Pac J Allergy Immunol; 1984 Dec; 2(2):325-8. PubMed ID: 6085274
    [No Abstract]   [Full Text] [Related]  

  • 16. PfEMP1 as a target of human immunity and a vaccine candidate against malaria.
    Beeson JG; Chan JA; Fowkes FJ
    Expert Rev Vaccines; 2013 Feb; 12(2):105-8. PubMed ID: 23414401
    [No Abstract]   [Full Text] [Related]  

  • 17. Proteosome-hydrophobic 'foot' malaria peptide vaccines for Plasmodium falciparum and P. vivax.
    Lowell GH; Ballou WR; Smith LF; Zollinger WD; Hockmeyer WT
    Trans R Soc Trop Med Hyg; 1989; 83 Suppl():101-2. PubMed ID: 2696152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The main obstacle to a malaria vaccine: the malaria parasite.
    Miller LH; Good MF
    Vaccine; 1988 Apr; 6(2):104-6. PubMed ID: 3291447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for the development of an engineered sporozoite malaria vaccine.
    Nussenzweig V; Nussenzweig RS
    Adv Immunol; 1989; 45():283-334. PubMed ID: 2665440
    [No Abstract]   [Full Text] [Related]  

  • 20. Towards a malaria vaccine: what is in sight?
    del Giudice G
    Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.